Tailored strategies for radiation therapy in classical Hodgkin's lymphoma

Stephanie A. Terezakis, Yvette L. Kasamon

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Radiotherapeutic advances have contributed to the evolution of Hodgkin's lymphoma (HL) treatment paradigms. A reduction in radiation therapy (RT) field size and dose has the potential to significantly impact the therapeutic ratio by diminishing late toxicities while maintaining curability. Substantial progress in risk stratification has contributed to the development of tailored RT strategies which address both field design as well as dose. Technologic improvements have also enhanced the ability to adapt the RT technique to the individual patient. The refinement of the RT approach and its incorporation into current combined modality strategies in adult classical HL is the subject of ongoing investigation and is critically reviewed.

Original languageEnglish (US)
Pages (from-to)71-84
Number of pages14
JournalCritical Reviews in Oncology/Hematology
Issue number1
StatePublished - Oct 1 2012
Externally publishedYes

Bibliographical note

Funding Information:
Supported by the National Institutes of Health ( K23 CA124465 to Y.L.K.).


  • Hodgkin's lymphoma
  • Involved-field radiation therapy
  • Late effects
  • Radiation


Dive into the research topics of 'Tailored strategies for radiation therapy in classical Hodgkin's lymphoma'. Together they form a unique fingerprint.

Cite this